HRPT2 mutational analysis of typical sporadic parathyroid adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5015-5017

  Krebs, Linda J ^a   Shattuck, Trisha M ^a   Arnold, Andrew ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; DIAGNOSTIC VALUE; DNA FLANKING REGION; EXON; FEMALE; GENE FREQUENCY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID TUMOR; PRIORITY JOURNAL; RNA SPLICING; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADENOMA; DNA MUTATIONAL ANALYSIS; DNA, RECOMBINANT; FEMALE; GENE FREQUENCY; HUMANS; MALE; MUTATION; PARATHYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 24344498667     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0717     Document Type: Article

References (22)

1. Bondeson L, Sandelin K, Grimelius L 1993 Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 17:820-829
2. Roth SI 1962 Pathology of the parathyroids in hyperparathyroidism. Discussion of recent advances in the anatomy and pathology of the parathyroid glands. Arch Pathol 73:495-510
3. Schantz A, Castleman B 1973 Parathyroid carcinoma. A study of 70 cases. Cancer 31:600-605
4. Vetto JT, Brennan MF, Woodruf J, Burt M 1993 Parathyroid carcinoma: diagnosis and clinical history. Surgery 114:882-892
5. Sandelin K, Thompson NW, Bondeson L 1991 Metastatic parathyroid carcinoma: dilemmas in management. Surgery 110:978-988
6. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO 1992 Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724-731
7. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, Ordonez NG, Hickey RC 1983 Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery 94:906-915
8. Apel RL, Asa SL 2002 The parathyroid glands. In: LiVolsi VA, Asa SA, eds. Endocrine pathology. Philadelphia: Churchill Livingstone; 103-147
9. Bondeson L, Grimelius L, DeLellis RA, Lloyd R, Akerstrom G, Larsson C, Arnold A, Eng C, Shane E, Bilezikian JP 2004 Parathyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization classification of tumors, pathology and genetics tumors of endocrine origin. Lyon, France: International Agency for Research on Cancer Press; 124-127
10. Grimelius L, DeLellis RA, Bondeson L, Akerstrom G, Arnold A, Franssila KO, Hendy GN, Dupuy D, Eng C 2004 Parathyroid adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization classification of tumors, pathology and genetics tumors of endocrine origin. Lyon, France: International Agency for Research on Cancer Press; 124-132
11. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath III H, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680
12. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MJ, Heath III H 1995 Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-950
13. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ 2004 Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96-102
14. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT 2003 HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657-663
15. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C 2004 Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germ-line and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583-5591
16. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszcynski T, Resau JH, Meyerson M 2005 The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25:612-620
17. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-1729
18. Silverberg SJ, Bilzekian JP 2001 Clinical course of primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids: basic and clinical concepts. 2nd ed. San Diego: Academic Press; 387-398
19. Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S 1997 Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287-294
20. Shattuck TM, Costa J, Bernstein M, Jensen RT, Chung DC, Arnold A 2002 Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-β and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. J Clin Endocrinol Metab 87:3911-3914
21. Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, Zhao P, Tretiakova MS, Korpi-Hyovalti E, Burgess JR, Soo KC, Cheah WK, Cao B, Resau J, Morreau H, Teh BT 2004 Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629-6637
22. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF 2005 Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24:1272-1276